Literature DB >> 3533784

Production of type II heat-labile enterotoxin by Escherichia coli isolated from food and human feces.

B E Guth, C L Pickett, E M Twiddy, R K Holmes, T A Gomes, A A Lima, R L Guerrant, B D Franco, L R Trabulsi.   

Abstract

Escherichia coli strains isolated in Sao Paulo, Brazil, from feces of patients with diarrhea and from food samples produced toxin(s) that was shown to be related both immunologically and genetically to the recently characterized type II heat-labile enterotoxin of E. coli. The new isolates of type II heat-labile enterotoxin-producing E. coli belonged to five different serotypes and did not represent a single clone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533784      PMCID: PMC260202          DOI: 10.1128/iai.54.2.587-589.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli.

Authors:  S L Kunkel; D C Robertson
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

3.  Detection of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture.

Authors:  S T Donta; H W Moon; S C Whipp
Journal:  Science       Date:  1974-01-25       Impact factor: 47.728

4.  Role of toxigenic and invasive bacteria in acute diarrhea of childhood.

Authors:  R L Guerrant; R A Moore; P M Kirschenfeld; M A Sande
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

5.  Characterization of the Chinese hamster ovary cell assay for the enterotoxins of Vibrio cholerae and Escherichia coli and for specific antisera, and toxoid.

Authors:  R L Guerrant; L L Brunton
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

6.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

7.  Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis.

Authors:  D J Evans; D G Evans
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

9.  Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli.

Authors:  R L Guerrant; L L Brunton; T C Schnaitman; L I Rebhun; A G Gilman
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

10.  Purification and characterization of type II heat-labile enterotoxin of Escherichia coli.

Authors:  R K Holmes; E M Twiddy; C L Pickett
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

View more
  25 in total

1.  Virulence factors and biochemical characteristics of serotypes of Escherichia coli serogroup O29.

Authors:  B E Guth; R M Silva; M R Toledo; T M Lima; L R Trabulsi
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

Review 2.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

3.  Genetic diversity of heat-labile toxin expressed by enterotoxigenic Escherichia coli strains isolated from humans.

Authors:  M A Lasaro; J F Rodrigues; C Mathias-Santos; B E C Guth; A Balan; M E Sbrogio-Almeida; L C S Ferreira
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

4.  Expression of hurP, a gene encoding a prospective site 2 protease, is essential for heme-dependent induction of bhuR in Bordetella bronchiseptica.

Authors:  Natalie D King-Lyons; Kelsy F Smith; Terry D Connell
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

5.  Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation.

Authors:  P P Chang; J Moss; E M Twiddy; R K Holmes
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

6.  LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.

Authors:  Hesham F Nawar; Christopher J Greene; Chang Hoon Lee; Lorrie M Mandell; George Hajishengallis; Terry D Connell
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

7.  Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.

Authors:  Hesham F Nawar; Sergio Arce; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.

Authors:  Sergio Arce; Hesham F Nawar; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

9.  Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.

Authors:  Camila Mathias-Santos; Juliana F Rodrigues; Maria Elisabete Sbrogio-Almeida; Terry D Connell; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

10.  Characterization of hybrid toxins produced in Escherichia coli by assembly of A and B polypeptides from type I and type II heat-labile enterotoxins.

Authors:  T D Connell; R K Holmes
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.